Last updated at 22 Jun 2024 06:33 PM
Director
DIN: 10322151
Bommai Basavaraj Aditi is currently associated with 2 companies in various capacities such as Director and Partner. They serve as a Director at BLAZED PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10322151.Bommai Basavaraj Aditi has previously been associated with 1 company in roles such as Additional Director.Bommai Basavaraj Aditi is currently involved in 2 different roles. Their most recent position is with CENTURY TRAILS LLP as a Partner. The first company Bommai Basavaraj Aditi was appointed to as a director was BLAZED PHARMACEUTICALS PRIVATE LIMITED. Bommai Basavaraj Aditi is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Bommai Basavaraj Aditi is currently associated with 2 companies in various capacities such as Director and Partner. They serve as a Director at BLAZED PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10322151.Bommai Basavaraj Aditi has previously been associated with 1 company in roles such as Additional Director.Bommai Basavaraj Aditi is currently involved in 2 different roles. Their most recent position is with CENTURY TRAILS LLP as a Partner. The first company Bommai Basavaraj Aditi was appointed to as a director was BLAZED PHARMACEUTICALS PRIVATE LIMITED. Bommai Basavaraj Aditi is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Female
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (1)
Past Companies (1)
6 Months 3 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| BLAZED PHARMACEUTICALS PRIVATE LIMITED | Director | 30-Sep-2023 |